FDA Grants EUA to Idylla Ebola Virus Triage Test

The FDA granted an emergency use authorization for an Ebola diagnostic test developed in partnership by Janssen, Biocartis and the Belgium Institute of Tropical Medicine.

The Idylla Ebola Virus Triage Test detects Ebola RNA in venous whole blood in roughly 100 minutes.

The triage test builds upon prior diagnostics, streamlining the process by using a standardized automated system that requires minimal training for interpreting results.

The triage test differs from its counterparts in that blood samples collected in the sealed cartridge need no further manipulation, and the test does not require cold storage.

The EUA can be found here: www.fdanews.com/06-02-16-IdyllaEUA.pdf. — Joya Patel